Search

Resumen La pandemia por SARS-CoV-2 ha acelerado el proceso de digitalización de la asistencia sanitaria. El cambio en el paradigma puede suponer un reto tanto para los profesionales sanitarios como para los pacientes. En este artículo se muestran la opinión de pacientes con distintos niveles de familiaridad con las nuevas tecnologías y la perspectiva de los profesionales sanitarios sobre el nuevo paciente y las innovaciones tecnológicas.

The SARS-CoV-2 pandemic has accelerated the process of healthcare digitalization. This paradigm shift is a challenge for both healthcare professionals and patients. This article discusses the opinions of patients with different levels of familiarity with new technologies, as well as the perspective of healthcare professionals on new patients and technological innovations.La pandemia por SARS-CoV-2 ha acelerado el proceso de digitalización de la asistencia sanitaria. El cambio en el paradigma puede suponer un reto tanto para los profesionales sanitarios como para los pacientes. En este artículo se muestran la opinión de pacientes con distintos niveles de familiaridad con las nuevas tecnologías y la perspectiva de los profesionales sanitarios sobre el nuevo paciente y las innovaciones tecnológicas.

In recent years, there has been much discussion concerning the cervical fasciae. The aim of this study is to confirm and to describe the development of the alar fascia as well as its relationship with nearby structures. Histological preparations of 25 human embryos (6-8 weeks of development) and 25 human fetuses (9-12 weeks of development) were studied bilaterally using a conventional optical microscope. Our study confirms the existence of the alar fascia and permits three stages to be established during its development. The initial stage (1st), corresponding to the 6th week of development (Carnegie stages 18-19), is characterized by the beginning of the alar fascia primordium in the retroesophageal space at the level of C7-T1. In the formation stage (2nd), corresponding to the 7th and 8th weeks of development (Carnegie stages 20-23), the alar fascia primordium grows upwards and reaches the level of C2-C3. In the maturation stage (3rd), beginning in the 9th week of development, the visceral, alar and prevertebral fasciae can be identified. The alar fascia divides the retrovisceral space (retropharyngeal and retroesophageal) into two spaces: one anterior (between the alar fascia and the visceral fascia and extending from C1 to T1, named retropharyngeal or retroesophageal space according to the level) and the other posterior (between the alar fascia and the prevertebral fascia, named danger space). We suggest that this latter space be named the retroalar space. This study suggests that alar fascia development is related to mechanical factors and that the alar fascia permits the sliding of the pharynx and the oesophagus during swallowing.

Nutrition therapy and exercise form an essential tandem to maintain the functional capacity of patients and, therefore, improve your quality of life. Oral nutritional supplements are part of the medical nutrition treatment. The success of taking nutritional supplements, lies in the therapeutic adherence. The therapeutic adherence is defined by who as "the degree to which the behavior of a patient, in relation to the taking of medication, monitoring a diet or modifying life habits correspond to the recommendations agreed with the health professional ". There are some factors that limit its achievement. Therefore, we must identify them and have tools to solve them so that the patient does not interrupt the prescribed treatment, both from prevention and intervention.La terapia nutricional y el ejercicio forman un tándem imprescindible para mantener la capacidad funcional de los pacientes y, por ende, mejorar su calidad de vida. Los suplementos nutricionales por vía oral forman parte del tratamiento nutricional médico. El éxito de la toma de suplementos nutricionales, radica en la adherencia terapéutica. La adherencia terapéutica es definida por la OMS como “el grado en el que la conducta de un paciente, en relación con la toma de medicación, el seguimiento de una dieta o la modificación de hábitos de vida se corresponden con las recomendaciones acordadas con el profesional sanitario”. Hay una serie de factores que limitan su consecución. Por ello, hay que identificarlos y disponer de herramientas para solventarlos para que el paciente no interrumpa el tratamiento pautado, tanto desde la prevención como la intervención.

espanolLa terapia nutricional y el ejercicio forman un tandem imprescindible para mantener la capacidad funcional de los pacientes y, por ende, mejorar su calidad de vida. Los suplementos nutricionales por via oral forman parte del tratamiento nutricional medico. El exito de la toma de suplementos nutricionales, radica en la adherencia terapeutica. La adherencia terapeutica es definida por la OMS como “el grado en el que la conducta de un paciente, en relacion con la toma de medicacion, el seguimiento de una dieta o la modificacion de habitos de vida se corresponden con las recomendaciones acordadas con el profesional sanitario”. Hay una serie de factores que limitan su consecucion. Por ello, hay que identificarlos y disponer de herramientas para solventarlos para que el paciente no interrumpa el tratamiento pautado, tanto desde la prevencion como la intervencion. EnglishNutrition therapy and exercise form an essential tandem to maintain the functional capacity of patients and, therefore, improve your quality of life. Oral nutritional supplements are part of the medical nutrition treatment. The success of taking nutritional supplements, lies in the therapeutic adherence. The therapeutic adherence is defined by who as “the degree to which the behavior of a patient, in relation to the taking of medication, monitoring a diet or modifying life habits correspond to the recommendations agreed with the health professional“. There are some factors that limit its achievement. Therefore, we must identify them and have tools to solve them so that the patient does not interrupt the prescribed treatment, both from prevention and intervention.